Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP614238.RAkpH_2rbml5uK2vAHNGTTNV9CdRDfcjI-QFItGm3QJgM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP614238.RAkpH_2rbml5uK2vAHNGTTNV9CdRDfcjI-QFItGm3QJgM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP614238.RAkpH_2rbml5uK2vAHNGTTNV9CdRDfcjI-QFItGm3QJgM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP614238.RAkpH_2rbml5uK2vAHNGTTNV9CdRDfcjI-QFItGm3QJgM130_provenance.
- NP614238.RAkpH_2rbml5uK2vAHNGTTNV9CdRDfcjI-QFItGm3QJgM130_assertion description "[Platelet-derived growth factor-BB (PDGF-BB) enhances the invasive activity of malignant peripheral nerve sheath tumor (MPNST) cells through platelet-derived growth factor receptor (PDGFR) phosphorylation, whereas imatinib mesylate inhibited such activity, suggesting that targeting PDGFR-beta may result in the establishment of novel treatment for MPNST.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP614238.RAkpH_2rbml5uK2vAHNGTTNV9CdRDfcjI-QFItGm3QJgM130_provenance.
- NP614238.RAkpH_2rbml5uK2vAHNGTTNV9CdRDfcjI-QFItGm3QJgM130_assertion evidence source_evidence_literature NP614238.RAkpH_2rbml5uK2vAHNGTTNV9CdRDfcjI-QFItGm3QJgM130_provenance.
- NP614238.RAkpH_2rbml5uK2vAHNGTTNV9CdRDfcjI-QFItGm3QJgM130_assertion SIO_000772 19627534 NP614238.RAkpH_2rbml5uK2vAHNGTTNV9CdRDfcjI-QFItGm3QJgM130_provenance.
- NP614238.RAkpH_2rbml5uK2vAHNGTTNV9CdRDfcjI-QFItGm3QJgM130_assertion wasDerivedFrom befree-20150227 NP614238.RAkpH_2rbml5uK2vAHNGTTNV9CdRDfcjI-QFItGm3QJgM130_provenance.
- NP614238.RAkpH_2rbml5uK2vAHNGTTNV9CdRDfcjI-QFItGm3QJgM130_assertion wasGeneratedBy ECO_0000203 NP614238.RAkpH_2rbml5uK2vAHNGTTNV9CdRDfcjI-QFItGm3QJgM130_provenance.
- befree-20150227 importedOn "2015-02-27" NP614238.RAkpH_2rbml5uK2vAHNGTTNV9CdRDfcjI-QFItGm3QJgM130_provenance.